Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP9-PP and MVA-PP Malaria Vaccine Challenge Study
NCT00375128Phase 2Completed
- Sponsor
- European Vaccine Initiative
- Start
- Sep 2006
- Modality
- Viral Vector Vaccines, Viral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of FP9-PP, MVA-PP in malaria, sponsored by European Vaccine Initiative. Started Sep 2006; status: completed.
02
Drugs
FP9-PPMVA-PP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00375128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375128.